InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
1
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the full record of transactions filed by Seely Lynn, Director. Insider active across 2 companies, notably Blueprint Medicines Corp. In total, 8 filings have been recorded. Split: 1 buy · 0 sell. Total volume traded: €98k. Activity tracked since 2 June 2021. The latest transaction was disclosed on 14 March 2025 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Declarations8 total
175,000 shares@ US$0.6068100.0% of flowCommon StockSEC:0001415889-25-008509:0
Ideal exit: 9 Dec 2025 (T+270)
337,500 shares0Common StockSEC:0001415889-25-005768:0
2,242 shares0Common StockSEC:0001415889-24-016983:0
200,000 shares0Common StockSEC:0001209191-24-003269:0
2,600 shares0Common StockSEC:0001415889-23-010262:0
2,600 shares0Common StockSEC:0001415889-22-007128:0
2,250 shares0Common StockSEC:0001179110-21-006416:0
2,250 shares0Common StockSEC:0001179110-21-006416
8 of 8 declarations
About Seely Lynn
Lynn Seely is a Board Member at Blueprint Medicines Corp. She is involved in overseeing the company's operations and formulating strategies aimed at enhancing performance. Her expertise in the biopharmaceutical sector is beneficial for the organization.
